Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29224502

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Jan 25
First author
Connors JM

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2018 Jan 25;378(4):392-394. doi: 10.1056/NEJMe1715141.
    note
    Source null
    related pmid
    29224505
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2018 Feb;15(2):68. doi: 10.1038/nrclinonc.2017.209.
    note
    Source null
    related pmid
    29283169
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 Mar 1;378(9):878. doi: 10.1056/NEJMx180007.
    note
    Source null
    related pmid
    29490175
    relationship
    Erratum in
  4. citation
    Epidemiol Prev. 2018 Jan-Feb;42(1):3-4. doi: 10.19191/EP18.1.P003.002.
    note
    Source null
    related pmid
    29506348
    relationship
    Comment in
  5. citation
    N Engl J Med. 2018 Apr 19;378(16):1558-9. doi: 10.1056/NEJMc1802363.
    note
    Source null
    related pmid
    29671464
    relationship
    Comment in
  6. citation
    N Engl J Med. 2018 Apr 19;378(16):1559. doi: 10.1056/NEJMc1802363.
    note
    Source null
    related pmid
    29671465
    relationship
    Comment in
  7. citation
    N Engl J Med. 2018 Apr 19;378(16):1559-60. doi: 10.1056/NEJMc1802363.
    note
    Source null
    related pmid
    29671466
    relationship
    Comment in
  8. citation
    N Engl J Med. 2018 Apr 19;378(16):1560. doi: 10.1056/NEJMc1802363.
    note
    Source null
    related pmid
    29671468
    relationship
    Comment in
  9. citation
    Blood. 2018 Jul 19;132(3):339-340. doi: 10.1182/blood-2018-04-845438.
    note
    Source null
    related pmid
    29858234
    relationship
    Comment in
  10. citation
    Eur J Cancer. 2018 Nov;104:252-253. doi: 10.1016/j.ejca.2018.09.021.
    note
    Source null
    related pmid
    30342911
    relationship
    Comment in

Authors and identifiers

  1. name
    Connors JM
    type
    Author
  2. name
    Jurczak W
    type
    Author
  3. name
    Straus DJ
    type
    Author
  4. name
    Ansell SM
    type
    Author
  5. name
    Kim WS
    type
    Author
  6. name
    Gallamini A
    type
    Author
  7. name
    Younes A
    type
    Author
  8. name
    Alekseev S
    type
    Author
  9. name
    Illés Á
    type
    Author
  10. name
    Picardi M
    type
    Author
  11. name
    Lech-Maranda E
    type
    Author
  12. name
    Oki Y
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Connors JM
    type
    Author
  2. name
    Jurczak W
    type
    Author
  3. name
    Straus DJ
    type
    Author
  4. name
    Ansell SM
    type
    Author
  5. name
    Kim WS
    type
    Author
  6. name
    Gallamini A
    type
    Author
  7. name
    Younes A
    type
    Author
  8. name
    Alekseev S
    type
    Author
  9. name
    Illés Á
    type
    Author
  10. name
    Picardi M
    type
    Author
  11. name
    Lech-Maranda E
    type
    Author
  12. name
    Oki Y
    type
    Author
bibliography ids
  1. nci-bib-522ef162231d6e9e3a5e7a7b
book metadata
content sha256
f4c76c9e8a044918ca2405d50d9eebf40341577172b97533174d27359cef076f
document type
citation
dois
  1. 10.1056/NEJMoa1708984
electronic publication date
display
2017 Dec 10
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29224502
immutable id
pubmed:29224502@f4c76c9e8a044918ca2405d50d9eebf40341577172b97533174d27359cef076f
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
4
name
The New England journal of medicine
nlm unique id
0255562
pages
331-344
volume
378
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2018 Jan 25;378(4):392-394. doi: 10.1056/NEJMe1715141.
    note
    Source null
    related pmid
    29224505
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2018 Feb;15(2):68. doi: 10.1038/nrclinonc.2017.209.
    note
    Source null
    related pmid
    29283169
    relationship
    Comment in
  3. citation
    N Engl J Med. 2018 Mar 1;378(9):878. doi: 10.1056/NEJMx180007.
    note
    Source null
    related pmid
    29490175
    relationship
    Erratum in
  4. citation
    Epidemiol Prev. 2018 Jan-Feb;42(1):3-4. doi: 10.19191/EP18.1.P003.002.
    note
    Source null
    related pmid
    29506348
    relationship
    Comment in
  5. citation
    N Engl J Med. 2018 Apr 19;378(16):1558-9. doi: 10.1056/NEJMc1802363.
    note
    Source null
    related pmid
    29671464
    relationship
    Comment in
  6. citation
    N Engl J Med. 2018 Apr 19;378(16):1559. doi: 10.1056/NEJMc1802363.
    note
    Source null
    related pmid
    29671465
    relationship
    Comment in
  7. citation
    N Engl J Med. 2018 Apr 19;378(16):1559-60. doi: 10.1056/NEJMc1802363.
    note
    Source null
    related pmid
    29671466
    relationship
    Comment in
  8. citation
    N Engl J Med. 2018 Apr 19;378(16):1560. doi: 10.1056/NEJMc1802363.
    note
    Source null
    related pmid
    29671468
    relationship
    Comment in
  9. citation
    Blood. 2018 Jul 19;132(3):339-340. doi: 10.1182/blood-2018-04-845438.
    note
    Source null
    related pmid
    29858234
    relationship
    Comment in
  10. citation
    Eur J Cancer. 2018 Nov;104:252-253. doi: 10.1016/j.ejca.2018.09.021.
    note
    Source null
    related pmid
    30342911
    relationship
    Comment in
outcomes validated
false
pmid
29224502
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
2413033bebdf51f80c0ad96b7f15b844a0501d1288d332af05c74319d6fadc71
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Jan 25
precision
day
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29224502/
title
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

Preserved source evidence · Not medical advice